Last reviewed · How we verify
NCT06742151
Evaluation of the Prevalence Rate and Related Risk Factors of Ridge Preservation
trial testing implant can be placed or not in Dental Implants in 133 participants. Completed in 31 March 2019.
3 January 2018
Quick facts
| Lead sponsor | Chimei Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 133 |
| Start date | 10 April 2014 |
| Primary completion | 3 January 2018 |
| Estimated completion | 31 March 2019 |
Drugs / interventions tested
- implant can be placed or not
Conditions studied
- Dental Implants — all drugs for Dental Implants →
Sponsor
Chimei Medical Center
Who can join
Adults 21 to 81, any sex, with Dental Implants. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Treated by dental implant is a well document and popular therapy nowadays. Placement of a dental implant in an ideal three-dimensional position is critical in achieving a predictable long-term success. However, healing of an extraction socket involves bone remodeling, which inevitably leads to atrophic changes of the alveolar ridge. Studies have shown that most of the resorption occurs during the first 3 months of healing, although dimensional changes can be observed up to 1 year after tooth extraction, resulting in approximately 50% reduction of the bucco-lingual dimension of the alveolar ridge, mainly due to the resorption of the bundle bone plate. Therefore, the timing of implant placement in extraction sockets can influence the surgery operability and treatment period of time. The classifications of timing of implant placement in extraction sockets as following: Type I: immediate implant placement: implant placement immediately following tooth extraction and as part of the same surgical procedure. Type II: early implant placement: surgery after complete soft tissue coverage of the socket (typically 4\~8 weeks). Type III: early implant placement: implant surgery after substantial clinical and/or radiographic bone fill of the socket (typically 12\~16 weeks). Type IV: late implant placement: surgery at healed site (typically more than 16 weeks). Considering of technique sensitivity and treatment time consuming, early implant placement is the most acceptable clinically. Many techniques have been developed to maintain the architecture of residual alveolar ridges and regenerative techniques for socket preservation is one of them. This procedure has been widely tested in controlled and uncontrolled studies with various materials and clinical approaches. However, this procedure may require longer treatment period compare to conventional or early implant placement protocol. Meanwhile, there is no study revealed how often and when does socket preservation need to prevent the residual ridge deformity in our daily clinical practice. The aim of the study is try to retrospectively find out the possible advantages and percentage of ridge preservation after tooth extraction in order to understand whether the socket preservation technique is necessary after tooth extraction, and the possible factors which might affect the clinical decision-making.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06742151
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dental Implants
Currently open trials in the same condition.
- NCT07346391 — Augmentation of Peri-implant Keratinized Mucosa Using a Combination of Free Gingival Graft Strip With Platelet-Rich Fibr · NA · recruiting
- NCT07073196 — Single Implant Crowns Supported by Narrow or Standard Diameter Implants in Molar Sites · NA · recruiting
- NCT06808854 — Variable-thread Versus Standard Dental Implants for Replacing Missing Teeth · NA · recruiting
- NCT07088679 — Natural Bioactive Gel for Peri-Implantitis · NA · recruiting
- NCT06960460 — Study Evaluating the Performance and Safety in the Medium and Long Term of Global D ZygoFixU System · NA · recruiting
Other Chimei Medical Center trials
Trials by the same sponsor.
- NCT06666361 — Middle-aged and Older Adults with Hypertension in Rural Communities · NA · recruiting
- NCT06447441 — Clinical Outcomes Of Mega-dosage Supplementations Of Cholecalciferol In Critically Ill Patients With Sepsis · NA · not yet recruiting
- NCT05493774 — Preliminary Exploration of Applying Multi-person Simulation Training to Improve Nurse-led Burn and Scald Nursing Care · NA · completed
- NCT06907004 — Developing a Exercise Program for Patients Undergoing Hematopoietic Stem Cell Transplantation · completed
- NCT06429020 — Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06742151 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chimei Medical Center
- Last refreshed: 24 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06742151.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing